Bio Protocol vs Parcl — how do they compare? Bio Protocol trades at Rp518.09 (market cap Rp1,17T, Rp248,44M 24h volume), while Parcl trades at Rp118.79 (market cap Rp48,53M, Rp4,66M 24h volume). The key difference: Bio Protocol is far larger — about 24108.8× Parcl's market cap, and Bio Protocol's circulating supply is 2,2B / 3,3B BIO (68%) versus 412,3M / 1B PRCL (42%) for Parcl. Which is the better fit depends on your goals — on Pluang, investors hold Bio Protocol for 16 Days and Parcl for 15 Days on average.
| BIO | PRCL | |
|---|---|---|
Market Cap | Rp1,17T | Rp48,53M |
Volume (24h) | Rp248,44M | Rp4,66M |
Circulating Supply | 2,2B / 3,3B BIO (68%) | 412,3M / 1B PRCL (42%) |
Typical Hold Time | 16 Days | 15 Days |
Signals from Pluang's Aura AI — not financial advice
Bio Protocol (BIO) trades at Rp521.46 with a market cap of Rp1.16T, showing bearish technical signals as moving averages indicate selling pressure while oscillators remain neutral. The token's circulating supply of 2.2M out of 3.3M max supply (68% circulation) suggests controlled token distribution. Current price sits near the pivot point of Rp521 with immediate support at Rp508 and resistance at Rp530. Recent market activity shows average hold time of 16 days, indicating relatively short-term trading patterns in the current bearish environment.
Overall outlook remains cautious with technical indicators favoring sellers, though oversold RSI conditions may present short-term bounce opportunities. Key risks include continued bearish momentum and low trading volumes, while potential upside could come from any positive ecosystem developments or market-wide crypto recovery. Investors should monitor support levels closely for entry points.
Parcl (PRCL) is trading at Rp118.79, showing a bearish technical bias with moving averages signaling sell pressure, though oscillators suggest potential short-term recovery. The token has a market cap of Rp49.06M with 42% of its 1M max supply in circulation. Key support lies at Rp110, with resistance at Rp124. No major protocol updates or ecosystem news are reported recently.
Overall outlook is cautious; oversold RSI hints at a bounce, but weak market structure and low liquidity pose risks. Opportunities include accumulation near support, while major risks involve high volatility and limited adoption. Investors should monitor volume for trend confirmation.
What Pluang investors did over the last 30 days
BIO Protocol enables global communities of scientists, patients, and investors to collectively fund, develop, and co-own new drugs and therapeutics through its network of Biotech Decentralized Autonomous Organizations (BioDAOs). The protocol's innovative approach addresses critical gaps in traditional scientific funding, particularly in areas such as rare diseases, longevity research, and emerging health challenges.
Read more on BIO →The Parcl Ecosystem—comprising Parcl, Parcl Labs, and Parcl Limited—develops and governs the Parcl Protocol, a decentralized platform enabling users to take long or short positions on real-world real estate prices. By leveraging world-class real estate data from Parcl Labs, Parcl aims to create a liquid market around the largest asset class globally. The PRCL token powers the ecosystem, offering governance rights, access to Parcl Labs’ data and analytics, and network incentives.
Read more on PRCL →